RAI | Ela-2 | MMP-8 | NGAL | AKI Probability (%) |
---|---|---|---|---|

− | − | ^{a} | ^{a} | 0 |

− | + | ^{a} | ^{a} | 5 |

+ | − | ^{a} | ^{a} | 5.3 |

+ | + | ^{a} | ^{a} | 27.3 |

− | ^{a} | − | ^{a} | 0 |

− | ^{a} | + | ^{a} | 4.3 |

+ | ^{a} | − | ^{a} | 4.9 |

+ | ^{a} | + | ^{a} | 24.1 |

− | ^{a} | ^{a} | − | 0 |

− | ^{a} | ^{a} | + | 4.4 |

+ | ^{a} | ^{a} | − | 6.8 |

+ | ^{a} | ^{a} | + | 23.8 |

− | − | − | ^{a} | 0 |

− | − | + | ^{a} | 0 |

− | + | − | ^{a} | 0 |

− | + | + | ^{a} | 7.4 |

+ | − | − | ^{a} | 0 |

+ | − | + | ^{a} | 8.8 |

+ | + | − | ^{a} | 11.1 |

+ | + | + | ^{a} | 31.4 |

The probability of day 3 AKI, determined as a percentage of patients with AKI in a given biomarker delineated subpopulation is shown for each biomarker profile. Individual rates and patient flow maps are depicted in Supplemental Material C.

↵a Biomarker not included for the particular analysis.